Video

The Challenge of Drug Adherence for Specialty Pharmacy

Author(s):

Davy James, Associate Editor

Shannon Ambrose, senior director of Specialty Solutions at Prime Therapeutics, discusses the factors that negatively impact medication adherence for specialty drugs.

Shannon Ambrose, senior director of Specialty Solutions at Prime Therapeutics, discusses the factors that negatively impact medication adherence for specialty drugs.

This video was shot at the Armada Health Care 2014 Specialty Pharmacy Summit and Expo in Las Vegas, Nevada.

Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
Pharmacist Spotlight: Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS
April 17th 2025

Pharmacist Spotlight: Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS

PT Staff Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Microscopic View of Blood Cells Related to Aplastic Anemia
April 16th 2025

Allogenic T Regulatory Cell Product CK0801 Granted FDA Orphan Drug Designation for Aplastic Anemia Treatment

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Pharmacist in specialty pharmacy preparing oral oncolytics -- Image credit: Monet | stock.adobe.com
April 15th 2025

Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy Practice

Natalie Kaufman, PharmD Nicole Bentivegna, PharmD, BCOP Roger Orr, PharmD, BCOP
Medical syringe for liquid 5 ml. White medical syringe with a cap, isolated on a blue background.
April 14th 2025

FDA Approves Vyvgart Hytrulo Prefilled Syringe With Self-Injection for Generalized Myasthenia Gravis, CIDP

Luke Halpern, Assistant Editor